Sneezing News and Research

RSS

Human rhinovirus found to manipulate genes

Sneezing, runny nose and chills? You might blame the human rhinovirus (HRV), which causes 30 to 50 percent of common colds. But in reality, it's not the virus itself but HRV's ability to manipulate your genes that is the true cause of some of the most annoying cold symptoms.

26 Oct 2008

Qld uni student diagnosed with tuberculosis

A student at the Queensland University of Technology (QUT) in Brisbane has been diagnosed with tuberculosis (TB) and as a result 160 staff and students at the University are being screened for the disease.

14 Oct 2008

Steroids aid recovery from pneumonia, UT Southwestern researchers say

Adding corticosteroids to traditional antimicrobial therapy might help people with pneumonia recover more quickly than with antibiotics alone, UT Southwestern Medical Center scientists have found.

14 Oct 2008

Combo of flu shot and COLD-FX cuts cold and flu by a third

A new study has shown the benefit of annual flu vaccinations for seniors along with Canada's top cold and flu-fighting product COLD-FX.

17 Sep 2008

Hand foot and mouth disease rife in Singapore

According to reports in the media, Singapore is facing a possible outbreak of Hand Foot and Mouth disease (HFMD).

26 Aug 2008

Structure and composition of hepatitis B virus now mapped

Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus.

28 Jul 2008

When it comes to catching an infection, planes no riskier than airports

A study carried out by the Australian Transport Safety Bureau has found there is no greater risk of catching an infection on a plane than in any other crowded and confined space.

10 Jun 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Study explains why steroid therapy for sinusitis and asthma loses its punch over time

Scientists at Johns Hopkins have outlined a new path for potential therapies to combat inflammation associated with sinusitis and asthma based on a new understanding of the body's earliest immune response in the nose and sinus cavities.

29 Apr 2008

Taro Pharmaceutical receives final FDA approval for Cetirizine Hydrochloride oral solution

Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride oral solution, 1 mg / 1 mL ("Cetirizine Oral Solution").

22 Apr 2008

CDC issues measles travel warning for Israel

As Americans travel to Israel for the Jewish holiday of Passover, the Centers for Disease Control and Prevention advises all travelers to ensure they are protected from measles before departing, because of a measles outbreak in Israel.

16 Apr 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

Allergies dramatically impact sufferers' moods and how they feel about themselves

A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions.

24 Mar 2008

Physical therapy helps symptoms of urinary incontinence in women

A study published in the Annals of Internal Medicine (March 18, 2008) reports that pelvic floor muscle training, in conjunction with bladder training, resolved the symptoms of urinary incontinence in women.

20 Mar 2008

New research shows why winter is the season for flu

Researchers in the United States believe they have discovered why flu and other respiratory viruses are more prevalent in winter.

3 Mar 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008